PENNINGTON, N.J. and SAN DIEGO, April 14, 2021 /PRNewswire/ -- OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company" or "OncoSec"), a biotechnology company focused on cytokine-based intratumoral ...

Researchers from SUTD developed a microsize-gap multiple-shot electroporation (M2E) device that could improve the effectiveness of delivering cancer drugs at a lower cost, globally. Researchers from ...

Technique instantly delivers controlled doses directly into cytosol with no reliance on endocytosis or effects on cell viability, the team reports. Scientists report on the development of a ...

Researchers from the Singapore University of Technology and Design (SUTD) have developed a microsize-gap multiple-shot electroporation (M2E) device that could improve the effectiveness of delivering ...

Inovio Develops Cordless Electroporation Device for Delivering DNA Vaccines New Hand-Held, Cordless Electroporation Device Designed to Facilitate Mass Vaccination March 03, 2010 03:30 AM Eastern ...

Janssen Pharmaceuticals has paired up with Ichor Medical Systems to develop and market DNA-based vaccine products to treat chronic hepatitis B (HBV). The partners will use the startup's TriGrid ...

PENNINGTON, N.J. and SAN DIEGO, June 14, 2021 /PRNewswire/ -- OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company" or "OncoSec"), today announced the appointment of Jeffrey Silverman as Vice ...

SAN DIEGO--(BUSINESS WIRE)--Ichor Medical Systems, Inc. (Ichor) announced today that it has entered into a product development collaboration and worldwide license agreement with Janssen ...

SAN DIEGO--(BUSINESS WIRE)--Ichor Medical Systems, Inc. announced today that it has entered into a Collaboration and License Agreement with Pfizer. Ichor's TriGrid™ intramuscular electroporation ...

Just a little zap and temporary pores open. Inovio Biomedical (San Diego) is banking on this process, known as electroporation, to substantially change vaccine delivery. It has just unveiled a new ...

PENNINGTON, N.J. and SAN DIEGO, April 14, 2021 /PRNewswire/ — OncoSec Medical Incorporated (NASDAQ:ONCS) (the “Company” or “OncoSec”), a biotechnology company focused on cytokine-based intratumoral ...